← Back
Finding 2619Emerging EvidenceValidation V0

Researchers unveil benchmark-neutral pricing for long-term, nonreplicable insurance and pensions, using the Growth Optimal Portfolio as numeraire; BN prices undercut risk-neutral levels while averting insurance--finance arbitrage of the first kind.

75%Confidence
1Evidence objects
v1Version
DraftStatus

Evidence trail

Finding relationships

qualifiesFinding 2619 → Finding 262275%
Knowledge status

This Finding was extracted from the configured corpus. It is versioned, traceable, and may evolve through editorial review or new corpus evidence.